News GenoScreen Corporate
World TB Day: GenoScreen participates to the International Tuberculosis Conference in Brussels!
On March 21st, GenoScreen will participate in the "International Conference on Tuberculosis" in Brussels.
The Deeplex-MycTB solution presented in Les Echos
Check out the Les Echos article on our innovative Deeplex-MycTB solution, a next-generation test for combating multidrug-resistant TB.
GenoScreen finalizes a €1 million fundraising campaign to continue its international expansion
GenoScreen announced today that it has completed a €1 million fundraising campaign with private investors.
Pioneer company since 2001 in sequencing, genotyping and bioinformatics, GenoScreen provides innovative services and solutions in genomics to address the needs of academic and industrial research teams. At the forefront of genomics in France, GenoScreen develops innovation programs that fuel its technological lead and generate high-performance analytical, products and control services.
GenoScreen in La Gazette of Nord-Pas de Calais
Discover La Gazette Nord-Pas de Calais article about our company "GenoScreen dissects DNA"
Meet us at BioFIT 2018!
On the 4th and 5th of December 2018, GenoScreen will participate at the 7th edition of the BioFIT business convention which will take place this year in Lille Grand Palais.
Become a GenoScreen Team Member
Join the GenoScreen team, we are looking for a Technical Sales Engineer, Genomics Specialty, apply!
Improving, through the genomic approach, the diagnosis, monitoring and follow-up of polluted sites: the conclusions of the BioDISSPOL project
GenoScreen will present the conclusions of the BioDISSPOL project on November 28 at Pollutec Lyon during the panel discussion: "Microbial Biomarkers : Application to the diagnosis and management of polluted sites".